Effect of glomerular filtration rate and proteinuria on medical cost among screened subjects

Clinical and Experimental Nephrology

Volumn 17, Issue 3, 2013, Pages 372-378

  Iseki, Kunitoshi ^a   Iseki, Chiho ^a   Kurahashi, Issei ^b   Watanabe, Tsuyoshi ^c  

^a UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

eGFR; Medical cost; Outcomes; Proteinuria

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NATIONAL HEALTH INSURANCE; PROTEINURIA; SCREENING TEST; SEX RATIO;

ADULT; AGED; FEMALE; GLOMERULAR FILTRATION RATE; HEALTH CARE COSTS; HUMANS; JAPAN; MALE; MASS SCREENING; MIDDLE AGED; PROTEINURIA; RENAL INSUFFICIENCY, CHRONIC;

EID: 84879409885     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-012-0718-z     Document Type: Article

References (17)

1. Wen CP, Cheng TYD, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462293 adults in Taiwan. Lancet. 2008;371:2173-82.
2. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-305.
3. Levey AS, de Jong PE, Coresh J, et al. The definition, classification and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80:17-28.
4. Boulware LE, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in US adults: a cost-effectiveness analysis. JAMA. 2003;290:3101-14.
5. Yamagata K, Iseki K, Nitta K, et al. Chronic kidney disease perspectives in Japan and the importance of urinalysis screening. Clin Exp Nephrol. 2008;12:1-8.
6. Imai E, Yamagata K, Iseki K, et al. Kidney disease screening program in Japan: history, outcome, and perspectives. Clin J Am Soc Nephrol. 2007;2:1360-6.
7. Chrysochou C, Kalra PA. Epidemiology and natural history of atherosclerotic renovascular disease. Prog Cardiovasc Dis. 2009;52:184-95.
8. Japanese Society for Dialysis Therapy. An overview of regular dialysis treatment in Japan as of Dec. 31, 2005. Tokyo: Japanese Society for Dialysis Therapy; 2006.
9. Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375:2073-81.
10. Kondo M, Yamagata K, Hoshi SL, et al. Cost-effectiveness of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol. 2012;16:279-91.
11. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982-92.
12. Iseki K, Iseki C, Ikemiya Y, Fukiyama K. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int. 1996;49:800-5.
13. Iseki K. Role of urinalysis in the diagnosis of chronic kidney disease (CKD). Jap Med Assoc J. 2011;54:27-30.
14. Meguid El Nahas A, Bello AK. Chronic kidney disease: the global challenge. Lancet. 2005;365: 331-40.
15. Yamagata K, Makino H, Akizawa T, Advisory Committee for FROM-J, et al. Design and methods of a strategic outcome study for chronic kidney disease: frontier of Renal Outcome Modifications in Japan. Clin Exp Nephrol. 2010;14:144-51.
16. Brenner BM, Lawler EV, Mackenzie HS. The hyperfiltration theory; a paradigm shift in nephrology. Kidney Int. 1996;49:1774-7.
17. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580-91. Japan